Compliance
This section focuses on health care compliance and regulations – both national and state – including the ACA. It includes changes in health care law, regulation, and court decisions and their impact on health insurance professionals, employers, and individuals.
U.S. House of Representatives Speaker Paul Ryan called on Wednesday for an end to Obamacare's financial protections for people with serious medical conditions, saying these consumers should be placed in state high-risk pools.
From the campaign trail to the halls of Congress, drug makers have spent much of the last year enduring withering criticism over the rising cost of drugs. It doesn’t seem to be working.
Many years ago there was an automobile dealer who pitched his cars on late night television. His commercials were presented in a near shout and with a staccato delivery.
Health Plan of Nevada, a UnitedHealthCare company, is gearing up for the next open enrollment period after reports of it leaving several states.
The Obama administration tightened rules Monday for private insurance plans that administer most Medicaid benefits for the poor, limiting profits, easing enrollment and requiring minimum levels of participating doctors.
UnitedHealthcare’s decision to quit insurance exchanges in about 30 states next year has patient advocates concerned that fewer options could force consumers to pay more for coverage and have a smaller choice of network providers.
President Obama's health-care reform law made government health insurance available to more people living in poverty or near poverty by expanding Medicaid. The hope was to improve people's physical health, but new research shows an important effect on financial health: The law has helped many poor Americans pay off the collection agent.
Two federal agencies just released some new research that probably isn’t going over too well in the White House.
Health insurance companies are laying the groundwork for substantial increases in ObamaCare premiums, opening up a line of attack for Republicans in a presidential election year.
Some people with cancer, HIV and multiple sclerosis have better access to high-cost specialty drugs in marketplace plans this year, yet a significant proportion of these plans still place many expensive drugs in cost-sharing categories that require the highest patient out-of-pocket costs, according to a new analysis.